Dose-Ranging, Safety And Efficacy Of Cathflo Activase (Alteplase) For The Treatment Of Central Catheter Occlusion In Neonates And Infants; Phase I.

Trial Profile

Dose-Ranging, Safety And Efficacy Of Cathflo Activase (Alteplase) For The Treatment Of Central Catheter Occlusion In Neonates And Infants; Phase I.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2016

At a glance

  • Drugs Alteplase (Primary)
  • Indications Catheter thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Sep 2011 Planned end date changed from 1 Dec 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 20 May 2009 Actual patient number (12) added as reported by ClinicalTrials.gov.
    • 20 May 2009 Planned end date changed from Dec 2008 to Dec 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top